ScreenerHero

DYAI Dyadic International, Inc.

NAS · US · Healthcare · Biotechnology · dyadic.com
0.4565USD+0.71%Mkt Cap: 18.29M $P/E: —

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Produ…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap18.29M USD
Enterprise Value18.45M USD
Revenue (TTM)3.80M USD
Gross Profit-1.09M USD
Net Income (TTM)-7.36M USD
Revenue/Share0.11 USD
Last Price0.4565 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.42
PEG—
EV/EBITDA—
EV/Revenue4.85
P/S4.78
P/B-6.87
EPS (TTM)-0.23
EPS (Forward)-0.32
52W Range
0.34009% of range1.600
52W High1.600 USD
52W Low0.3400 USD
Profitability
Gross Margin-88.25%
Oper. Margin-212.82%
EBITDA Margin0.00%
Profit Margin-597.63%
ROE-597.58%
ROA-74.05%
Growth
Revenue Growth-0.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.70M USD
CapEx (TTM)—
FCF Margin-126.48%
FCF Yield-26.30%
Net Debt1.93M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity4.11
Current Ratio1.65
Quick Ratio1.14
Book Value/Sh-0.07 USD
Cash/Share0.09 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.500 USD
Upside (mean)+1104.8%
Target Range4.000 USD – 7.000 USD
4.000+1104.8% to mean7.000
# Analysts2
Ownership
Shares Out.40.06M
Float27.50M
Insiders22.90%
Institutions12.32%
Short Interest
Short Ratio1.2d
Short % Float0.66%
Short % Out.0.57%
Shares Short227.16K
Short (prev mo.)164.74K
Technical
SMA 500.6552 (-30.3%)
SMA 2000.8091 (-43.6%)
Beta0.96
S&P 52W Chg16.45%
Avg Vol (30d)182.88K
Avg Vol (10d)142.24K
Technical Indicators
RSI (14)37.8
MACD-0.0645
MACD Signal-0.0863
MACD Hist.+0.0218
BB Upper0.5187 USD
BB Middle0.4470 USD
BB Lower0.3752 USD
BB Width32.12%
ATR (14)0.0601 USD
Vol Ratio (20d)0.66x